These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24205859)

  • 1. An evaluation of the latest in vitro tools for drug metabolism studies.
    Costa A; Sarmento B; Seabra V
    Expert Opin Drug Metab Toxicol; 2014 Jan; 10(1):103-19. PubMed ID: 24205859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HepaRG cell line: a unique in vitro tool for understanding drug metabolism and toxicology in human.
    Andersson TB; Kanebratt KP; Kenna JG
    Expert Opin Drug Metab Toxicol; 2012 Jul; 8(7):909-20. PubMed ID: 22568886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental models for predicting drug absorption and metabolism.
    Alqahtani S; Mohamed LA; Kaddoumi A
    Expert Opin Drug Metab Toxicol; 2013 Oct; 9(10):1241-54. PubMed ID: 23687990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptomyces cytochromes P450: applications in drug metabolism.
    Lamb DC; Waterman MR; Zhao B
    Expert Opin Drug Metab Toxicol; 2013 Oct; 9(10):1279-94. PubMed ID: 23738914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo.
    Gómez-Lechón MJ; Castell JV; Donato MT
    Chem Biol Interact; 2007 May; 168(1):30-50. PubMed ID: 17134688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organotypic systems in drug metabolism and toxicity: challenges and opportunities.
    Dash A; Blackman BR; Wamhoff BR
    Expert Opin Drug Metab Toxicol; 2012 Aug; 8(8):999-1014. PubMed ID: 22632603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A long-term three dimensional liver co-culture system for improved prediction of clinically relevant drug-induced hepatotoxicity.
    Kostadinova R; Boess F; Applegate D; Suter L; Weiser T; Singer T; Naughton B; Roth A
    Toxicol Appl Pharmacol; 2013 Apr; 268(1):1-16. PubMed ID: 23352505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results.
    Yoon M; Campbell JL; Andersen ME; Clewell HJ
    Crit Rev Toxicol; 2012 Sep; 42(8):633-52. PubMed ID: 22667820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-based in vitro models for predicting drug permeability.
    Sarmento B; Andrade F; da Silva SB; Rodrigues F; das Neves J; Ferreira D
    Expert Opin Drug Metab Toxicol; 2012 May; 8(5):607-21. PubMed ID: 22424145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro drug metabolism testing using blood-monocyte derivatives.
    Gómez-Icazbalceta G; González-Sánchez I; Moreno J; Cerbón MA; Cervantes A
    Expert Opin Drug Metab Toxicol; 2013 Dec; 9(12):1571-80. PubMed ID: 23984653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of acute renal failure on drug metabolism.
    Philips BJ; Lane K; Dixon J; Macphee I
    Expert Opin Drug Metab Toxicol; 2014 Jan; 10(1):11-23. PubMed ID: 24074057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definition of metabolism-dependent xenobiotic toxicity with co-cultures of human hepatocytes and mouse 3T3 fibroblasts in the novel integrated discrete multiple organ co-culture (IdMOC) experimental system: results with model toxicants aflatoxin B1, cyclophosphamide and tamoxifen.
    Li AP; Uzgare A; LaForge YS
    Chem Biol Interact; 2012 Jul; 199(1):1-8. PubMed ID: 22640811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro methods in human drug biotransformation research: implications for cancer chemotherapy.
    Hariparsad N; Sane RS; Strom SC; Desai PB
    Toxicol In Vitro; 2006 Mar; 20(2):135-53. PubMed ID: 16359840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mouse with humanized liver as an animal model for predicting drug effects and for studying hepatic viral infection: where to next?
    Yoshizato K; Tateno C
    Expert Opin Drug Metab Toxicol; 2013 Nov; 9(11):1419-35. PubMed ID: 23978259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-content analysis in toxicology: screening substances for human toxicity potential, elucidating subcellular mechanisms and in vivo use as translational safety biomarkers.
    O'Brien PJ
    Basic Clin Pharmacol Toxicol; 2014 Jul; 115(1):4-17. PubMed ID: 24641563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity assessments of nonsteroidal anti-inflammatory drugs in isolated mitochondria, rat hepatocytes, and zebrafish show good concordance across chemical classes.
    Nadanaciva S; Aleo MD; Strock CJ; Stedman DB; Wang H; Will Y
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):272-80. PubMed ID: 23811329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of intrinsic clearance for prediction of human hepatic clearance.
    Chao P; Uss AS; Cheng KC
    Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):189-98. PubMed ID: 20073997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary hepatocyte cultures as prominent in vitro tools to study hepatic drug transporters.
    Ramboer E; Vanhaecke T; Rogiers V; Vinken M
    Drug Metab Rev; 2013 May; 45(2):196-217. PubMed ID: 23368091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biotransformation of diclofenac and effects on the metabolome of primary human hepatocytes upon repeated dose exposure.
    Mueller D; Müller-Vieira U; Biemel KM; Tascher G; Nüssler AK; Noor F
    Eur J Pharm Sci; 2012 Apr; 45(5):716-24. PubMed ID: 22330146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.